Wolverine Asset Management’s Raptor Pharmaceutical RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-9,400
Closed -$84K – 1475
2016
Q3
$84K Buy
+9,400
New +$66.8K ﹤0.01% 995

Wolverine Asset Management's RPTP Position: Q4 2016 in Review

Wolverine Asset Management sold out of Raptor Pharmaceutical (RPTP) in Q4 2016, closing a stake of 9,400 shares — an estimated $84K sold.

Wolverine Asset Management first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $84K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Wolverine Asset Management reported no remaining Raptor Pharmaceutical position as of Q4 2016 after selling out during the quarter.
  • Wolverine Asset Management sold 9,400 Raptor Pharmaceutical shares in Q4 2016, an estimated $84K.
  • Wolverine Asset Management first reported a position in Raptor Pharmaceutical in Q3 2016 and held it in 1 quarter.
  • Wolverine Asset Management's Raptor Pharmaceutical position peaked at $84K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.